Literature DB >> 23444119

Barriers for integrating personalized medicine into clinical practice: a qualitative analysis.

Mehdi Najafzadeh1, Jennifer C Davis, Pamela Joshi, Carlo Marra.   

Abstract

Personalized medicine-tailoring interventions based on individual's genetic information-will likely change routine clinical practice in the future. Yet, how practitioners plan to apply genetic information to inform medical decision making remains unclear. We aimed to investigate physician's perception about the future role of personalized medicine, and to identify the factors that influence their decision in using genetic testing in their practice. We conducted three semi-structured focus groups in three health regions (Fraser, Vancouver coastal, and Interior) in British Columbia, Canada. In the focus groups, participants discussed four topics on personalized medicine: (i) physicians' general understanding, (ii) advantages and disadvantages, (iii) potential impact and role in future clinical practice, and (iv) perceived barriers to integrating personalized medicine into clinical practice. Approximately 36% (n = 9) of physicians self-reported that they were not familiar with the concept of personalized medicine. After introducing the concept, the majority of physicians (68%, n = 19 of 28) were interested in incorporating personalized medicine in their practice, provided they have access to the necessary knowledge and tools. Participants mostly believed that genetic developments will directly affect their practice in the future. The key concerns highlighted were physician's access to clinical guidelines and training opportunities for the use of genetic testing and data interpretation. Despite the challenges that personalized medicine can create, in general, physicians in the focus groups expressed strong interest in using genetic information in their practice if they have access to the necessary knowledge and tools.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23444119     DOI: 10.1002/ajmg.a.35811

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  16 in total

1.  'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project.

Authors:  Jason L Vassy; Kurt D Christensen; Melody J Slashinski; Denise M Lautenbach; Sridharan Raghavan; Jill Oliver Robinson; Jennifer Blumenthal-Barby; Lindsay Zausmer Feuerman; Lisa Soleymani Lehmann; Michael F Murray; Robert C Green; Amy L McGuire
Journal:  Per Med       Date:  2015       Impact factor: 2.512

2.  A Viewpoint on the Information Sharing Paradox.

Authors:  Shane P Stenner; William Rice; Scott D Nelson
Journal:  Appl Clin Inform       Date:  2020-07-08       Impact factor: 2.342

3.  A theory-informed systematic review of clinicians' genetic testing practices.

Authors:  Jean L Paul; Hanna Leslie; Alison H Trainer; Clara Gaff
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

4.  How Primary Care Providers Talk to Patients about Genome Sequencing Results: Risk, Rationale, and Recommendation.

Authors:  Jason L Vassy; J Kelly Davis; Christine Kirby; Ian J Richardson; Robert C Green; Amy L McGuire; Peter A Ubel
Journal:  J Gen Intern Med       Date:  2018-01-26       Impact factor: 5.128

5.  Do physicians think genomic medicine will be useful for patient care?

Authors:  Sridharan Raghavan; Jason L Vassy
Journal:  Per Med       Date:  2014       Impact factor: 2.512

6.  Evaluating Approaches for Communication About Genomic Influences on Body Weight.

Authors:  Susan Persky; Richard L Street
Journal:  Ann Behav Med       Date:  2015-10

7.  Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE).

Authors:  Mehdi Najafzadeh; Karissa M Johnston; Stuart J Peacock; Joseph M Connors; Marco A Marra; Larry D Lynd; Carlo A Marra
Journal:  BMC Health Serv Res       Date:  2013-10-31       Impact factor: 2.655

8.  Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area.

Authors:  Aihua Li; David Meyre
Journal:  Curr Psychiatry Rev       Date:  2014-05

9.  Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocol.

Authors:  Stuart Wright; Gavin Daker-White; William Newman; Katherine Payne
Journal:  Wellcome Open Res       Date:  2018-03-08

10.  The clinical impact of using complex molecular profiling strategies in routine oncology practice.

Authors:  Jean-François Laes; Philippe Aftimos; Philippe Barthelemy; Joaquim Bellmunt; Guy Berchem; Carlos Camps; Ramón de Las Peñas; Ana Finzel; Jesús García-Foncillas; Petteri Hervonen; Ibrahim Wahid; Timo Joensuu; Louis Kathan; Anthony Kong; James Mackay; Christos Mikropoulos; Kefah Mokbel; Jean-Loup Mouysset; Sergey Odarchenko; Timothy J Perren; Rika Pienaar; Carlos Regonesi; Shadi Salem Alkhayyat; Abdul Rahman El Kinge; Omalkhair Abulkhair; Khaled Morsi Galal; Hady Ghanem; Fadi El Karak; Angel Garcia; Gregori Ghitti; Helen Sadik
Journal:  Oncotarget       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.